20 articles
Mendelian randomization links circulating inflammatory proteins to retinal microvascular changes, heart disease risk, and lifespan — establishing causal direction.
A comprehensive review reveals how inflammaging—the fusion of aging and inflammation—fuels cardiovascular disease through senescence, mitochondrial dysfunction, and gut dysbiosis.
German study explored how lifelong inflammatory burden contributes to cardiac aging by measuring heart rate variability changes.
Chinese study of 4,157 adults finds cumulative CTI index outperforms single measurements for cardiovascular risk prediction.
New biomarker combining inflammation and glucose metabolism predicts stroke risk better than single measurements in middle-aged adults.
CTI index combining inflammation and insulin resistance shows 111% higher death risk in 5,847 Chinese adults.
A 2025 review maps the molecular mechanisms driving cardiovascular aging—from inflammaging to ECM remodeling—and outlines emerging therapies.
Advanced spatial mapping shows vascular regions drive cardiac aging through inflammation and senescence accumulation.
New research reveals how age-related blood cell changes may increase pericarditis and myocarditis risk in healthy adults.
New research shows C-reactive protein levels can identify additional cardiovascular risk in patients already receiving optimal care.
Researchers created synthetic immune receptors that boost macrophages' ability to clear cellular debris, reducing inflammation in liver and heart disease.
A distinct immune remodeling process — separate from classical immunosenescence — predicts arterial stiffness with surprising accuracy.
New research reveals how gut barrier breakdown activates cardiac JNK2, driving age-related atrial fibrillation through inflammation.
New CT scan technology can spot dangerous fat around arteries that predicts heart attacks better than traditional methods.
A 2-year clinical trial testing Juice Plus+ products against low-grade inflammation and biological aging markers in overweight seniors was terminated before completion.
New research reveals how modulating immune cells in arterial plaques could reduce cardiovascular disease progression.
New composite index combining triglyceride-glucose levels with frailty scores dramatically improves cardiovascular risk prediction in older adults.
New biomarker soluble endoglin shows promise for early detection of cardiovascular and metabolic disorders in blood tests.
Cardiologist explains how chronic inflammation damages arteries and triggers blood clots before cholesterol becomes problematic.
Dr. Jamnadas reveals how cooking methods and food choices create AGEs that damage your body and accelerate aging at the cellular level.
